Noa Rivlin
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
Papers in
-
- Epigenetics and DNA Methylation 7
- Pluripotent Stem Cells Research 3
- Renal and related cancers 2
- Oncology 10
- Cancer-related Molecular Pathways 9
- Cancer Cells and Metastasis 2
- Co-authors
- Varda Rotter (14 shared papers)Ran Brosh (6 shared papers)Moshe Oren (1 shared paper)Alina Molchadsky (10 shared papers)Naomi Goldfinger (10 shared papers)Rachel Sarig (6 shared papers)Osnat Ezra (6 shared papers)Shalom Madar (5 shared papers)
- Journals
- Cell Death and Differentiation (3 papers)Carcinogenesis (2 papers)Journal of Hepatology (1 paper)HemaSphere (1 paper)Cell Reports (1 paper)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Noa Rivlin
17 papers receiving 1.5k citations
Noa Rivlin's Hit Papers
Peers
Comparison fields: 5 of 99
- Cancer Research 407
- Oncology 665
- Molecular Biology 923
- Biotechnology 88
- Drug Discovery 1
Countries citing papers authored by Noa Rivlin
This map shows the geographic impact of Noa Rivlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noa Rivlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noa Rivlin more than expected).
Fields of papers citing papers by Noa Rivlin
This network shows the impact of papers produced by Noa Rivlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noa Rivlin. The network helps show where Noa Rivlin may publish in the future.
Co-authors
The 25 scholars most cited alongside Noa Rivlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis Hit paper breakdown → | 2011 | 768 |
| 2 | 2010 | 133 | |
| 3 | 2010 | 130 | |
| 4 | 2013 | 94 | |
| 5 | 2011 | 83 | |
| 6 | 2010 | 64 | |
| 7 | 2012 | 56 | |
| 8 | 2014 | 45 | |
| 9 | 2012 | 44 | |
| 10 | 2014 | 44 | |
| 11 | 2012 | 34 | |
| 12 | 2014 | 33 | |
| 13 | 2017 | 17 | |
| 14 | 2014 | 16 | |
| 15 | 2010 | 8 | |
| 16 | 2023 | 1 | |
| 17 | 2022 | 1 |
About Noa Rivlin
Noa Rivlin is a scholar working on Molecular Biology, Oncology, Cancer Research, Epidemiology and Biotechnology, having authored 17 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (9 papers), Epigenetics and DNA Methylation (7 papers), Cancer, Hypoxia, and Metabolism (4 papers), Pluripotent Stem Cells Research (3 papers), Cancer, Lipids, and Metabolism (2 papers), Renal and related cancers (2 papers), Cancer Research and Treatments (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (407 citations), Oncology (665 citations), Molecular Biology (923 citations), Biotechnology (88 citations) and Drug Discovery (1 citation). Noa Rivlin has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Varda Rotter, Ran Brosh, Moshe Oren, Alina Molchadsky, Naomi Goldfinger, Rachel Sarig, Osnat Ezra, Shalom Madar, Ido Goldstein and Gabriela Koifman. Their work appears in journals such as Cell Death and Differentiation, Carcinogenesis, Journal of Hepatology, HemaSphere and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.